Previous 10 | Next 10 |
A recent 10-Q for IBIO mentions the word "plasma" just once. IBIO isn't a plasma company like ADMA and isn't developing a plasma-derived product for COVID-19 like KMDA. IBIO can make proteins in plants, such as plasma proteins, so can other. IBIO is late to the game with a recent ...
Should Biotech Penny Stocks Be On Your Watch List Right Now? What’s one of the top sectors to watch when it comes to penny stocks ? While some traders might say anything that’s moving, others pinpoint a few select sectors. In this case, biotech continues to offer m...
Taiwan Liposome (TLC) +89% after company secures Australian and Taiwan approval to initiate trial of inhaled malaria drug for COVID-19.Ocean Power Technologies (OPTT) +47%.Sunworks (SUNW) +45% on announcing $10M in Q3 project wins.Urban Tea (MYT) +31%.Hill International (H...
Are These On Your Penny Stocks To Watch List Right Now? This week we’ve got a ton of things to think about no matter if its penny stocks or blue-chips . Regardless of the broader repercussions that may come Monday morning, there are several penny stocks to watch based...
Did These Robinhood Penny Stocks Make Your Watch List? Whether you’re buying penny stocks on Robinhood , Webull, TD Ameritrade, or other brokers, the goal is the same: make money. Some platforms are easier to use than others. While there are certain platforms that allow m...
ADMA Biologics (ADMA) could be worth up to $16 per share in a buyout, according to Jefferies.That note on the thinly-traded $190M market cap name had the stock up about 15% to $2.52 in a manner of minutes. At current pixel time, it's ahead 4.3% to $2.29.ADMA at the start of Sep...
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 09, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived b...
ADMA Biologics (NASDAQ: ADMA ) launches COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary immunoassay that detects SARS-CoV-2 neutralizing antibodies in plasma. More news on: ADMA Biologics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Kensington Capital Acquisition (KCAC) +39% as QuantumScape goes public via Kensington Capital merger. More news on: FibroGen, Inc., Fulgent Genetics, Inc., Soligenix, Inc., Stocks on the move, , Read more ...
ImmunoRank Offers a Faster, Simpler, More Cost Effective Way to Identify High Titer Convalescent Plasma for Use in Both Treating COVID-19 Patients and for Creating COVID-19 Hyperimmune Globulins Proprietary Assay Developed in Collaboration with Leinco Technologies RAMSEY, N.J. and ...
News, Short Squeeze, Breakout and More Instantly...
2024-05-10 11:30:04 ET Raymond James analyst issues STRONG BUY recommendation for ADMA on May 10, 2024 09:52AM ET. The previous analyst recommendation was Strong Buy. ADMA was trading at $8.705 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...